These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 2540170)
81. Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. Marzocchetti A; Wuthrich C; Tan CS; Tompkins T; Bernal-Cano F; Bhargava P; Ropper AH; Koralnik IJ J Neurovirol; 2008 Oct; 14(5):455-8. PubMed ID: 18989816 [TBL] [Abstract][Full Text] [Related]
82. JC virus genotyping using formalin-fixed, paraffin-embedded renal tissues. Ikegaya H; Iwase H; Zheng HY; Nakajima M; Sakurada K; Takatori T; Fukayama M; Kitamura T; Yogo Y J Virol Methods; 2005 Jun; 126(1-2):37-43. PubMed ID: 15847917 [TBL] [Abstract][Full Text] [Related]
83. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Tada H; Rappaport J; Lashgari M; Amini S; Wong-Staal F; Khalili K Proc Natl Acad Sci U S A; 1990 May; 87(9):3479-83. PubMed ID: 2159152 [TBL] [Abstract][Full Text] [Related]
84. Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer. Gloss B; Chong T; Bernard HU J Virol; 1989 Mar; 63(3):1142-52. PubMed ID: 2536825 [TBL] [Abstract][Full Text] [Related]
85. Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene. Riccio A; Pedone PV; Lund LR; Olesen T; Olsen HS; Andreasen PA Mol Cell Biol; 1992 Apr; 12(4):1846-55. PubMed ID: 1549130 [TBL] [Abstract][Full Text] [Related]
86. Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. Marshall LJ; Dunham L; Major EO J Gen Virol; 2010 Dec; 91(Pt 12):3042-52. PubMed ID: 20826618 [TBL] [Abstract][Full Text] [Related]
87. Quantification of human polyomavirus JC in brain tissue and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy by competitive PCR. Drews K; Bashir T; Dörries K J Virol Methods; 2000 Jan; 84(1):23-36. PubMed ID: 10644084 [TBL] [Abstract][Full Text] [Related]
88. A 23-bp sequence element from human neurotropic JC virus is responsive to NF-kappa B subunits. Safak M; Gallia GL; Khalili K Virology; 1999 Sep; 262(1):178-89. PubMed ID: 10489351 [TBL] [Abstract][Full Text] [Related]
89. Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. Vaz B; Cinque P; Pickhardt M; Weber T J Neurovirol; 2000 Oct; 6(5):398-409. PubMed ID: 11031693 [TBL] [Abstract][Full Text] [Related]
90. Identification and characterization of a JC virus pentanucleotide repeat element binding protein: cellular nucleic acid binding protein. Liu M; Kumar KU; Pater MM; Pater A Virus Res; 1998 Nov; 58(1-2):73-82. PubMed ID: 9879764 [TBL] [Abstract][Full Text] [Related]
92. Discovery and characterization of novel trans-spliced products of human polyoma JC virus late transcripts from PML patients. Saribas AS; DeVoto J; Golla A; Wollebo HS; White MK; Safak M J Cell Physiol; 2018 May; 233(5):4137-4155. PubMed ID: 29044559 [TBL] [Abstract][Full Text] [Related]
93. SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expression in adrenocortical cells. Aigueperse C; Val P; Pacot C; Darne C; Lalli E; Sassone-Corsi P; Veyssiere G; Jean C; Martinez A Mol Endocrinol; 2001 Jan; 15(1):93-111. PubMed ID: 11145742 [TBL] [Abstract][Full Text] [Related]
94. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system. Chowdhury M; Kundu M; Khalili K Oncogene; 1993 Apr; 8(4):887-92. PubMed ID: 8384357 [TBL] [Abstract][Full Text] [Related]
95. An NF1-like protein functions as a repressor of the von Willebrand factor promoter. Jahroudi N; Ardekani AM; Greenberger JS J Biol Chem; 1996 Aug; 271(35):21413-21. PubMed ID: 8702923 [TBL] [Abstract][Full Text] [Related]
96. Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region. Ostapchuk P; Scheirle G; Hearing P Mol Cell Biol; 1989 Jul; 9(7):2787-97. PubMed ID: 2550788 [TBL] [Abstract][Full Text] [Related]
97. High affinity binding site for nuclear factor I next to the hepatitis B virus S gene promoter. Shaul Y; Ben-Levy R; De-Medina T EMBO J; 1986 Aug; 5(8):1967-71. PubMed ID: 3463507 [TBL] [Abstract][Full Text] [Related]
98. JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes. Marshall LJ; Moore LD; Mirsky MM; Major EO J Gen Virol; 2012 Mar; 93(Pt 3):651-661. PubMed ID: 22071512 [TBL] [Abstract][Full Text] [Related]
99. Modulation of JC virus transcription by C/EBPbeta. Romagnoli L; Wollebo HS; Deshmane SL; Mukerjee R; Del Valle L; Safak M; Khalili K; White MK Virus Res; 2009 Dec; 146(1-2):97-106. PubMed ID: 19747512 [TBL] [Abstract][Full Text] [Related]
100. Functional homology between the sequence-specific DNA-binding proteins nuclear factor I from HeLa cells and the TGGCA protein from chicken liver. Leegwater PA; van der Vliet PC; Rupp RA; Nowock J; Sippel AE EMBO J; 1986 Feb; 5(2):381-6. PubMed ID: 3709517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]